Submitted by Anonymous (not verified) on 22 September 2023 - 14:16
Human medicines European public assessment report (EPAR): Vantobra (previously Tobramycin PARI), tobramycin, Respiratory Tract Infections;Cystic Fibrosis, Date of authorisation: 18/02/2019, Revision: 5, Status: Authorised
Source: